Re: Urethral Bulking
- PMID: 39392526
- DOI: 10.1097/SPV.0000000000001585
Re: Urethral Bulking
Conflict of interest statement
The authors have declared they have no conflicts of interest.
References
-
- Fleischmann N, Chughtai B, Plair A, et al. Urethral bulking. Urogynecology (Phila) . 2024;30(8):667–682. doi:10.1097/SPV.0000000000001548. - DOI
-
- Guérin S, Khene ZE, Peyronnet B, et al. Google searches for stress urinary incontinence treatment options: a worldwide trend analysis in the synthetic mesh controversy era. World J Urol . 2023;41(8):2217–2223. doi:10.1007/s00345-023-04474-0. - DOI
-
- Serati M, Giammò A, Carone R, et al; Italian Society of Urodynamics. Bulking agents for the treatment of recurrent stress urinary incontinence: a suitable option? Minerva Urol Nephrol . 2022;74(6):747–754. doi:10.23736/S2724-6051.21.04269-5. - DOI
-
- Braga A, Caccia G, Papadia A, et al. Urethral bulking agents for the treatment of recurrent stress urinary incontinence: a systematic review and meta-analysis. Maturitas . 2022;163:28–37. doi:10.1016/j.maturitas.2022.05.007. - DOI
-
- Serati M, Soligo M, Braga A, et al; Publication Committee of the Italian Society of Urodynamics. Efficacy and safety of polydimethylsiloxane injection (Macroplastique®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow-up. BJU Int . 2019;123(2):353–359. doi:10.1111/bju.14550. - DOI
LinkOut - more resources
Full Text Sources